We are excited to announce that we have received a new NIH R01 to develop immune technologies to study lymphoma and develop novel therapeutics. We are actively recruiting postdocs and Ph.D. students on this project.
Read Georgia Tech article here:
Singh Laboratory @ Georgia Tech
by Ankur Singh
We are excited to announce that we have received a new NIH R01 to develop immune technologies to study lymphoma and develop novel therapeutics. We are actively recruiting postdocs and Ph.D. students on this project.
Read Georgia Tech article here:
by Ankur Singh
.
by Ankur Singh
Jan 15, 2020 Singh’s writes an opinion in “Nature Materials” on the emerging role of #microbiome, #immunity, and #nanomaterials in #inflammatory bowel disease and metabolic syndrome.
by Ankur Singh
Prof. Singh gave an invited talk to @NASA and @ncats_nih_gov on #immune #organoids & #technologies. Learned so much about @Space_Station @ISS_Research & in-space viable medical countermeasures while preparing this talk!
by Ankur Singh
Congrats to PhD student Matt Mosquera on winning a “2019 BMES Career Development Award”. @BMESociety’s Award supports dev. of underrepresented early career Grads/postdocs/junior faculty in #biomedical #engineering research. So proud!
by Ankur Singh
Congrats to PhD student Shivem Shah (@shivemshah) on receiving an @NIH @NIBIBgov T32 #Immunoengineering Training Fellowship for 2019-20. Shiv is studying #immune cell signaling using engineered immune tissues & plans to defend his PhD in ‘20. So proud of him!